Insights Into Century Therapeutics Inc (IPSC) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Century Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Century Therapeutics Inc is $41.11M. A total of 0.94 million shares were traded on the day, compared to an average of 973.53K shares.

In the most recent transaction, Pfeiffenberger Brent bought 30,745 shares of IPSC for 0.57 per share on Aug 18 ’25. In a previous transaction on Aug 04 ’25, Carr Douglas sold 296 shares at 0.53 per share. IPSC shares that SVP Finance & Operations owns now total 405,686.

Among the insiders who sold shares, Carr Douglas disposed of 4,904 shares on Jun 09 ’25 at a per-share price of $0.62. This resulted in the SVP Finance & Operations holding 405,982 shares of IPSC after the transaction. In another insider transaction, Farid Adrienne sold 552 shares at $0.62 per share on Jun 09 ’25. Company shares held by the Chief Operations Officer now total 250,141.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IPSC has a high of $1.86 and a low of $0.34.

As of this writing, IPSC has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.39. The company reported an EPS of -$0.37 in the last quarter

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IPSC’s latest balance sheet shows that the firm has $222.88M in Cash & Short Term Investments as of fiscal 2021. There were $25.12M in debt and $15.65M in liabilities at the time. Its Book Value Per Share was $2.43, while its Total Shareholder’s Equity was $396.24M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IPSC is Buy with a score of 4.43.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.